Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah J Griffiths-Jones

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Journal of Scleroderma and Related Disorders|July 5, 2021
Clinical trial protocol: PRednisolone in early diffuse cutaneous Systemic Sclerosis (PRedSS)Ariane L Herrick, Deborah J Griffiths-Jones, W David Ryder, et al.
Rheumatology (Oxford, England)|January 13, 2023
A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS)Deborah J Griffiths-Jones, Yvonne Sylvestre Garcia, W David Ryder, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Journal of Scleroderma and Related Disorders|July 5, 2021
Clinical trial protocol: PRednisolone in early diffuse cutaneous Systemic Sclerosis (PRedSS)Ariane L Herrick, Deborah J Griffiths-Jones, W David Ryder, et al.
Rheumatology (Oxford, England)|January 13, 2023
A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS)Deborah J Griffiths-Jones, Yvonne Sylvestre Garcia, W David Ryder, et al.
Pageof 1